DAFNA Capital Management’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $324K | Hold |
|
|||||
|
2024
Q2 | $333K | Hold |
|
|||||
|
2024
Q1 | $539K | Sell |
|
|||||
|
2023
Q4 | $278K | Hold |
|
|||||
|
2023
Q3 | $274K | Hold |
|
|||||
|
2023
Q2 | $325K | Hold |
|
|||||
|
2023
Q1 | $383K | Hold |
|
|||||
|
2022
Q4 | $513K | Hold |
|
|||||
|
2022
Q3 | $377K | Hold |
|
|||||
|
2022
Q2 | $597K | Hold |
|
|||||
|
2022
Q1 | $723K | Buy |
|
|||||
|
2021
Q4 | $511K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $203K | Sell |
|
|||||
|
2016
Q1 | $716K | Buy |
|
|||||
|
2015
Q4 | $580K | Buy |
|